Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Cara Reiter-Brennan"'
Publikováno v:
Contemporary Oncology, Vol 22, Iss 4, Pp 215-222 (2018)
Mutation of the isocitrate-dehydrogenase (IDH) enzymes is one of the central research topics regarding gliomagenesis. Indeed, 70% of gliomas are associated with a gain-of-function IDH mutation and consequently synthesize the oncometabolite, 2-hydroxy
Externí odkaz:
https://doaj.org/article/b1a77d009a014991bf285c860702dd43
Autor:
Frances M. Wang, Cara Reiter–Brennan, Zeina Dardari, Catherine H. Marshall, Khurram Nasir, Michael D. Miedema, Daniel S. Berman, Alan Rozanski, John A. Rumberger, Matthew J. Budoff, Omar Dzaye, Michael J. Blaha
Publikováno v:
American Journal of Preventive Cardiology, Vol 4, Iss , Pp 100119- (2020)
Background: Identifying cancer patients at high risk of CVD is important for targeting CVD prevention strategies and evaluating chemotherapy options in the context of cardiotoxicity. Coronary artery calcium (CAC), a strong marker of coronary atherosc
Externí odkaz:
https://doaj.org/article/1cd5e81535cc4e8bb5da96d372650ddc
Autor:
Omar Dzaye, Cara Reiter-Brennan, Albert D. Osei, Olusola A. Orimoloye, S. M. Iftekhar Uddin, Mohammadhassan Mirbolouk, Michael J. Blaha
Publikováno v:
Cardiology Research and Practice, Vol 2019 (2019)
The 2018 American Heart Association and American College of Cardiology (AHA/ACC) cholesterol management guideline considers current evidence on coronary artery calcium (CAC) testing while incorporating learnings from previous guidelines. More than an
Externí odkaz:
https://doaj.org/article/dbaef64fce5046e7b98dbacd1685680a
Autor:
Catherine Handy Marshall, Omar Dzaye, Clinton A. Brawner, K Visvanathan, Steven J. Keteyian, Zeina Dardari, Michael J. Blaha, Jonathan K. Ehrman, Mouaz H. Al-Mallah, Cara Reiter-Brennan, Lois Lamerato
Publikováno v:
Cancer. 127:1864-1870
The relation between cardiorespiratory fitness (CRF) and prostate cancer is not well established. The objective of this study was to determine whether CRF is associated with prostate cancer screening, incidence, or mortality.The Henry Ford Exercise T
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 105:2095-2104
Context The worldwide rise in the prevalence of cardiometabolic disease, and the introduction of therapeutic options for treating metabolic disease that also lower cardiovascular risk, calls for a restructuring of how we care for patients with cardio
Autor:
Cara Reiter-Brennan, Michael J. Blaha, Omar Dzaye, Olufunmilayo H. Obisesan, Olusola A Orimoloye, S. M. Iftekhar Uddin, Mohammadhassan Mirbolouk, Albert D. Osei
Publikováno v:
Cleveland Clinic Journal of Medicine. 87:231-239
The 2018 and 2019 guidelines from the American College of Cardiology and American Heart Association reflect the complexity of individualized cholesterol management. The documents address more detailed risk assessment, newer nonstatin cholesterol-lowe
Publikováno v:
Current Cardiology Reports
Purpose of Review The high burden of cardiovascular disease and the simultaneous obesity pandemic is placing an extraordinary strain on the health care system. In the current siloed care model, patients with cardiometabolic disease receive only fract
Publikováno v:
Precision Medicine in Cardiovascular Disease Prevention ISBN: 9783030750541
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9eaeac3324797be768a65ebbd11d8ea5
https://doi.org/10.1007/978-3-030-75055-8_4
https://doi.org/10.1007/978-3-030-75055-8_4
Publikováno v:
Cardiovascular Endocrinology & Metabolism
Cardiovascular disease (CVD) remains the leading cause of mortality in the United States, and the population of patients with cardiometabolic conditions, including obesity, metabolic syndrome and diabetes mellitus, continues to grow. There is a need
Autor:
Michael J. Blaha, Cara Reiter-Brennan, Garshasb P. Soroosh, Miguel Cainzos-Achirica, David Saxon, Robert H. Eckel
Publikováno v:
Cardiovasc Endocrinol Metab
The high prevalence of cardiovascular disease and worldwide diabetes epidemic has created an ever-increasing burden on the healthcare system. This calls for the creation of a new medicine subspecialty: cardiometabolic medicine. Using information from